Tetragon Partners GP Ltd Quant / Systematic

Location: Grand Cayman, Cayman Islands

CIK: 0001515070 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 13, 2026

Total Value: $635M (100.0% shares, 0.0% debt)

Holdings (39)

New Positions (10)

Increased Positions (16)

PATH UIPATH INC 53.0%
Value $336M (+20.2%) Shares 30,950,000 (+22.8%) Est. Cost Unrealized
DFTX DEFINIUM THERAPEUTICS INC 2.1%
Value $13.5M (+257.2%) Shares 286,990 (+43.5%) Est. Cost Unrealized
RLAY RELAY THERAPEUTICS INC 1.7%
Value $10.67M (+490.7%) Shares 570,311 (+214.1%) Est. Cost Unrealized
MBX MBX BIOSCIENCES INC 1.8%
Value $11.24M (+158.7%) Shares 203,543 (+39.9%) Est. Cost Unrealized
SLN SILENCE THERAPEUTICS PLC 1.3%
Value $8.392M (+152.7%) Shares 764,256 (+21.3%) Est. Cost Unrealized
IONS IONIS PHARMACEUTICALS INC 1.2%
Value $7.705M (+145.7%) Shares 97,173 (+132.7%) Est. Cost Unrealized
IMVT IMMUNOVANT INC 1.6%
Value $9.861M (+81.7%) Shares 255,934 (+17.1%) Est. Cost Unrealized
ALKS ALKERMES PLC 1.6%
Value $9.954M (+76.2%) Shares 189,979 (+18.9%) Est. Cost Unrealized
HRMY HARMONY BIOSCIENCES HLDGS IN 1.2%
Value $7.32M (+119.0%) Shares 201,036 (+68.5%) Est. Cost Unrealized
PHVS PHARVARIS N V 1.6%
Value $10.22M (+63.3%) Shares 295,627 (+33.4%) Est. Cost Unrealized
DYN DYNE THERAPEUTICS INC 1.2%
Value $7.921M (+69.3%) Shares 356,657 (+38.2%) Est. Cost Unrealized
ARWR ARROWHEAD PHARMACEUTICALS IN 1.7%
Value $10.64M (+33.4%) Shares 130,484 (+2.6%) Est. Cost Unrealized
KPTI KARYOPHARM THERAPEUTICS INC 0.4%
Value $2.445M (+778.1%) Shares 250,300 (+400.6%) Est. Cost Unrealized
AGIO AGIOS PHARMACEUTICALS INC 1.2%
Value $7.629M (+36.8%) Shares 205,579 (+24.7%) Est. Cost Unrealized
ACAD ACADIA PHARMACEUTICALS INC 0.7%
Value $4.247M (+31.9%) Shares 167,875 (+16.1%) Est. Cost Unrealized
TECX TECTONIC THERAPEUTIC INC 0.3%
Value $1.599M (+37.6%) Shares 46,516 (+23.8%) Est. Cost Unrealized